Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Aug. 7, 2024
The
main
challenge
in
diagnosing
and
treating
ulcerative
colitis
(UC)
has
prompted
this
study
to
discover
useful
biomarkers
understand
the
underlying
molecular
mechanisms.
Experimental Gerontology,
Journal Year:
2025,
Volume and Issue:
203, P. 112729 - 112729
Published: March 11, 2025
Rheumatoid
arthritis
(RA)
promotes
the
onset
and
progression
of
sarcopenia,
yet
mechanisms
co-morbidity
between
RA
sarcopenia
are
under-explored.
Therefore,
this
study
integrated
Gene
Expression
Omnibus
(GEO)
Genome-wide
association
studies
(GWAS)
data
to
comprehensively
identify
shared
genes,
associated
mechanisms,
biological
pathways
in
sarcopenia.
Utilizing
two
GEO
datasets-GSE226151,
which
includes
60
RNA-seq
samples
skeletal
muscle
from
healthy
aged,
pre-sarcopenia,
individuals,
GSE55235,
with
20
synovial
tissue
joints-we
performed
differentially
expressed
genes
analysis,
weighted
gene
co-expression
network
analysis
crosstalk
enrichment
for
these
genes.
Using
relevant
GWAS
datasets,
SMR
analyses
cis-eQTL
were
performed.
We
further
validated
identified
key
explored
potential
causal
associations
sarcopenia-related
traits.
25
involved
immune-inflammatory
response
pathways,
including
neutrophil
extracellular
trap
formation
Fc
gamma
receptor-mediated
phagocytosis.
six
core
genes:
NCF1,
FCGR2A,
FCGR3A,
SORL1,
FCGR3B,
ITGAX
(PSMR
<
0.05).
showed
that
FCGR2A
might
have
a
negative
appendicular
lean
mass,
whole
body
fat-free
positive
(P
Overall,
is
first
reveal
molecular
identifying
response-related
pathways.
Further
conducted
validate
emerging
as
drug
target
RA-associated
These
findings
provide
new
insights
into
comorbid
offering
therapeutic
targets
both
conditions.
Computational and Structural Biotechnology Journal,
Journal Year:
2024,
Volume and Issue:
23, P. 1348 - 1363
Published: March 28, 2024
Autoimmune
diseases
(ADs)
are
characterized
by
their
complexity
and
a
wide
range
of
clinical
differences.
Despite
patients
presenting
with
similar
symptoms
disease
patterns,
reactions
to
treatments
may
vary.
The
current
approach
personalized
medicine,
which
relies
on
molecular
data,
is
seen
as
an
effective
method
address
the
variability
in
these
diseases.
This
review
examined
pathologic
classification
ADs,
such
multiple
sclerosis
lupus
nephritis,
over
time.
Acknowledging
limitations
inherent
classification,
focus
shifted
achieve
deeper
insight
into
heterogeneity.
study
outlined
established
methods
findings
from
categorizing
systemic
erythematosus
(SLE)
four
subtypes,
inflammatory
bowel
(IBD)
two,
rheumatoid
arthritis
(RA)
three,
(MS)
single
subtype.
It
was
observed
that
high
inflammation
subtype
IBD,
RA
subtype,
MS
"inflammation
&
EGF"
share
similarities.
These
subtypes
all
display
consistent
pattern
primarily
driven
activation
JAK-STAT
pathway,
drugs
being
those
target
this
signaling
pathway.
Additionally,
identifying
markers
uniquely
associated
various
within
same
disease,
able
describe
differences
between
detail.
expected
contribute
development
treatment
plans
for
establish
strong
basis
tailored
approaches
treating
autoimmune
Journal of Inflammation Research,
Journal Year:
2025,
Volume and Issue:
Volume 18, P. 925 - 947
Published: Jan. 1, 2025
Inflammatory
bowel
disease
(IBD)
is
a
non-specific
inflammatory
of
digestive
tract,
primarily
manifesting
as
ulcerative
colitis
(UC)
and
Crohn's
(CD).
The
precise
etiology
IBD
remains
elusive.
interplay
genetic
factors,
environmental
influences,
intestinal
microbiota
contributes
to
the
establishment
an
uncontrolled
immune
environment
within
intestine,
which
can
progressively
lead
atypical
hyperplasia
ultimately
malignancy
over
long
period.
This
colorectal
malignant
tumor
that
arises
from
chronic
referred
colitis-associated
cancer
(CAC).
Dysregulation
in
quantity
functionality
neutrophils
plays
significant
role
onset,
progression,
recurrence
IBD,
well
transition
CAC.
Neutrophils
affect
pathophysiology
through
various
mechanisms,
including
production
reactive
oxygen
species
(ROS),
degranulation,
release
mediators
chemokines,
formation
neutrophil
extracellular
traps
(NETs).
These
processes
induce
DNA
mutations,
thereby
facilitating
development
colon
cancer.
Given
incomplete
understanding
mechanisms
underlying
CAC,
effective
treatment
prevention
strategies
remain
challenging.
Consequently,
comprehensive
review
functional
roles
CAC
essential
for
advancing
our
pathogenesis
identifying
potential
therapeutic
targets.
Molecular Immunology,
Journal Year:
2025,
Volume and Issue:
179, P. 42 - 51
Published: Feb. 6, 2025
To
examine
the
protective
effect
and
mechanism
of
original
extract
Dendrobium
officinale
(DE)
on
gastric
lesions
caused
by
aspirin
(ASA)
facilitate
development
traditional
Chinese
medicine
products.
In
this
study,
a
rat
model
was
established,
then
rats
were
treated
with
DE
for
5
days.
We
found
that
ASA-induced
mucosal
detachment
hemorrhagic
in
improved
after
supplementation.
Meanwhile,
effectively
inhibits
secretion
inflammatory
mediators
(IL-6,
IL-1β,
TNF-α,
MPO,
COX-2)
upregulates
activity
antioxidant
core
components
(T-SOD,
GSH-Px)
defense
factors
(TFFs,
EGF,
EGFR)
tissues.
It
further
exerted
defensive
mucosa
association
NF-κB/Nrf-2/HO-1
signaling.
conclusion,
protects
from
oxidative
stress,
improves
its
defenses,
as
well
being
potential
nutrient
future,
preventing
lesions.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 28, 2025
Neutrophils,
the
most
abundant
myeloid
cells
in
human
peripheral
blood,
serve
as
first
defense
line
against
infection
and
are
also
significantly
involved
initiation
progression
of
cancer.
In
colorectal
cancer
(CRC),
neutrophils
exhibit
a
dual
function
by
promoting
tumor
events
exerting
antitumor
activity,
which
is
related
to
heterogeneity
neutrophils.
The
neutrophil
extracellular
traps
(NETs),
gut
microbiota,
various
within
microenvironment
(TME)
shaping
heterogeneous
This
article
provides
an
updated
overview
complex
functions
underlying
mechanisms
CRC
their
pivotal
role
guiding
prognosis
assessment
therapeutic
strategies,
aiming
offer
novel
insights
into
neutrophil-associated
treatment
approaches
for
CRC.